Distinct features of SARS-CoV-2-specific IgA response in COVID-19 patients

Humoral immune response to SARS-CoV-2 showed an early response of IgA, instead of IgM, in COVID-19 patients. As highlighted by this study, enhanced IgA responses observed in severe COVID-19 might confer damaging effects in severe COVID-19. https://bit.ly/3fA7c1I

Detalles Bibliográficos
Autores principales: Yu, Hai-qiong, Sun, Bao-qing, Fang, Zhang-fu, Zhao, Jin-cun, Liu, Xiao-yu, Li, Yi-min, Sun, Xi-zhuo, Liang, Hong-feng, Zhong, Bei, Huang, Zhi-feng, Zheng, Pei-yan, Tian, Li-feng, Qu, Hui-Qi, Liu, De-chen, Wang, Er-yi, Xiao, Xiao-jun, Li, Shi-yue, Ye, Feng, Guan, Li, Hu, Dong-sheng, Hakonarson, Hakon, Liu, Zhi-gang, Zhong, Nan-shan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2020
Materias:
Agora
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7236821/
https://www.ncbi.nlm.nih.gov/pubmed/32398307
http://dx.doi.org/10.1183/13993003.01526-2020
Descripción
Sumario:Humoral immune response to SARS-CoV-2 showed an early response of IgA, instead of IgM, in COVID-19 patients. As highlighted by this study, enhanced IgA responses observed in severe COVID-19 might confer damaging effects in severe COVID-19. https://bit.ly/3fA7c1I

Ejemplares similares